Archaea Already Invented the RNA Trick Medicine Uses Now

Single-celled microbes living in near-boiling water have been quietly using the RNA Trick that modern medicine relies on — and they got there first. Researchers reporting in the journal Cell this month show that heat-loving archaea carry large numbers of chemical modifications in their cellular RNA, including a backbone swap that drug designers borrowed to keep therapeutic RNA stable inside the body, according to the research write-up published by Phys.org.

The finding reframes a piece of medical history. RNA therapeutics depend on small chemical edits that protect fragile genetic instructions from being chewed up before they can work. The RNA Trick is one of the most useful: a nonbridging oxygen atom in the phosphate backbone is replaced by a sulfur atom, a change known as a phosphorothioate, which shields the molecule from enzymes that would otherwise degrade it. Medicine began using the edit in the age of RNA therapeutics. The new work suggests single-celled organisms were there first, swapping the same atoms to harden their own RNA against extreme heat.

What the team actually found

Schraga Schwartz, a professor at the Weizmann Institute of Science in Rehovot, Israel, teamed up with Dina Grohmann, a professor at the University of Regensburg, to hunt through the planet's most ancient microbial lineage. Working from the extensive strain collection of the German Archaea Center, the Regensburg group isolated RNA molecules from several extremophilic archaea under controlled conditions, and the Israeli team then analyzed the samples molecule by molecule.

What they found was a landscape of modifications far richer than in organisms living at moderate temperatures — and, crucially, one that shifts with the environment. Unlike creatures in mild climates, these heat-loving microbes tune numerous RNA edits depending on surrounding conditions. It is the first demonstration that hyperthermophilic archaea load their cellular RNAs with so many modifications, and the paper published in Cell also tracks down the writer enzymes that install the edits: the molecular machinery behind the pattern.

That machinery matters because the modification at the center of the study is the same one used in therapeutic RNA. In medicine, swapping in sulfur protects the drug against degradation by nucleases, the enzymes that chop up stray genetic material. Nature appears to have arrived at the identical solution, not for delivering medicine, but for surviving boiling water.

Why it matters for medicine

Grohmann put the discovery in context: "Archaea had already developed this chemical form of RNA stabilization before we made it usable for medical applications in the age of RNA therapeutics. As is so often the case, archaea are one step ahead of us."

The practical upshot is for biotechnology. RNA-based medicines are still held back by stability — a dose that falls apart too quickly never reaches its target. By studying how microbes keep RNA intact under punishing conditions, engineers may learn new ways to harden tomorrow's treatments, from cancer vaccines to genetic therapies. The researchers note the findings open new perspectives for understanding RNA stability under extreme conditions, with potential use in developing future RNA-based therapeutics that survive longer in the bloodstream.

It is worth remembering how young the human version of this technology really is. Large-scale RNA medicine only took off with the pandemic-era mRNA shots, a blink compared with the eons microbes have been refining their chemistry. Archaea belong to one of the oldest branches of life, and their toolkit has been field-tested in boiling springs and deep-sea vents ever since. Medicine did not invent the wheel here; it found one that had been rolling all along.

There is a broader pattern here. The mRNA vaccines of the pandemic years worked partly because of modified nucleosides such as pseudouridine, another borrowed piece of natural chemistry that kept synthetic RNA from tripping immune alarms. The archaeal discovery extends that story backward by billions of years: evolution had already stress-tested these edits in the harshest environments on the planet, and medicine is still catching up to the results.

A note of caution is due. This is fundamental biology, not a new drug. The study identifies the modifications and their writers in a handful of cultivated strains; whether the same chemistry shows up across the wider tree of extremophiles, and whether engineers can actually borrow it for therapy, remains to be shown. Still, the direction of travel is unmistakable: some of the best RNA engineers on Earth may be single cells living in hot springs.

More science coverage: Bangladesh's first nuclear reactor just came alive and the Ebola outbreak passing nine thousand cases in the DRC.